Results 171 to 180 of about 7,115 (194)

Olmesartan Medoxomil/Amlodipine

Drugs, 2012
Mark Sanford
exaly  

Modulation of carbon tetrachloride-induced hepatic oxidative stress, injury and fibrosis by olmesartan and omega-3

Chemico-Biological Interactions, 2014
Mohamed E Shaker, Ahmed Shaaban, Tarek M Ibrahim   +2 more
exaly  

Novel amides and esters prodrugs of olmesartan: Synthesis, bioconversion, and pharmacokinetic evaluation

Bioorganic and Medicinal Chemistry Letters, 2010
Mohammed I El-Gamal, Hye Jin Chung, Chang-Hyun Oh   +2 more
exaly  

Design, synthesis, bioconversion, and pharmacokinetics evaluation of new ester prodrugs of olmesartan

European Journal of Medicinal Chemistry, 2011
Mohammed I El-Gamal, Hye Jin Chung, Young Wook Choi   +2 more
exaly  

Olmesartan

2013
openaire   +1 more source

Pharmacokinetics and safety of olmesartan medoxomil in combination with either amlodipine or atenolol compared to respective monotherapies in healthy subjects

Fundamental and Clinical Pharmacology, 2009
Juliane Bolbrinker, Reinhold Kreutz
exaly  

Pharmacokinetics of Amlodipine and Olmesartan After Administration of Amlodipine Besylate and Olmesartan Medoxomil in Separate Dosage Forms and as a Fixed‐Dose Combination

Journal of Clinical Pharmacology, 2008
Robert Noveck
exaly  

Olmesartan-associated sprue-like enteropathy: a systematic review with emphasis on histopathology

Human Pathology, 2016
Govind Bhagat, Peter Hr Green, Benjamin Lebwohl   +2 more
exaly  

Clinical impacts of additive use of olmesartan in hypertensive patients with chronic heart failure: the supplemental benefit of an angiotensin receptor blocker in hypertensive patients with stable heart failure using olmesartan (SUPPORT) trial

European Heart Journal, 2015
Makoto Nakagawa, K Nishimiya
exaly  

OLMESARTAN

2004
openaire   +1 more source